Weston Family Acquires Pharmacy Chain Boots
The Canadian family group purchases the 177-year-old retailer for $8.9 billion.
Updated on Oct. 25, 2026 in Healthcare
Live Poll
Do you believe private equity ownership of major local retail chains is good for your community?
The Canadian branch of the Weston family has finalized a deal to acquire the pharmacy and beauty chain Boots for $8.9 billion. This acquisition marks the end of an era for 85-year-old Stefano Pessina, who concludes his 20-year involvement with the company.
Why it matters
The sale follows a recent resurgence in Boots beauty sales and increased demand for weight-loss medications. The deal concludes a complex period that included a failed attempt to re-float the business in 2024.
The deal values the 177-year-old pharmacy chain at $8.9 billion, falling short of the $10 billion target. The combined global business had previously achieved a turnover of nearly $140 billion by 2023.
The players
Stefano Pessina
A veteran industry figure who managed the pharmacy chain for two decades.
Weston family
A prominent business family that acquired the Boots chain through its Canadian branch.
KKR
A global investment firm that partnered to take the company private in 2007.
Walgreens
A major United States pharmacy retailer that previously merged with the business.
Boots
A long-standing pharmacy and beauty retail chain headquartered in Nottingham.
The details
Stefano Pessina, who initially acquired Unichem in 1997 to gain scale in Britain, previously merged and then de-merged the pharmacy operations with US peer Walgreens. The Nottingham-based retailer was once taken private with KKR in 2007 for approximately £11 billion.
Timeline
1997: Stefano Pessina acquired the pharmacy firm Unichem.
2007: Pessina and KKR took the pharmacy business private.
2012: The merger with Walgreens was officially announced.
2024: A planned re-float of the Boots business was dropped.
October 25, 2026: The acquisition of Boots by the Weston family was reported.
Market Landscape
This acquisition marks a major shift in retail pharmacy ownership following years of cross-border consolidation and public-to-private cycles. The move signals a strategic change in how the global business positions itself against competitors following the 2012 Walgreens-Alliance Boots merger.
Customers are unlikely to see immediate changes in daily shopping as the ownership structure evolves. Future developments may impact product availability or store services depending on the new long-term retail strategy.
The takeaway
This transaction underscores the volatility of high-profile retail pharmacy chains in the modern market. Private ownership changes of this scale often signal a pivot in operational focus rather than immediate changes to consumer experience.
Further reading
For more on the changing dynamics of the pharmacy sector, visit the Healthcare section.
Source note: This article includes information reported by MoneyWeek.
Live Poll
Do you believe private equity ownership of major local retail chains is good for your community?
